2-AMINO-3-BROMO-4-FLUOROBENZOIC ACID, 95%, 100mg

2,2'-(1,4-Phenylene)bis(1-phenylethane-1,2-dione), 95.0%, 25g

tert-Butyl ((1R,3S)-3-hydroxycyclopentyl)(methyl)carbamate, 98%, 500mg

3-Bromo-5-fluorobenzotrifluoride, 97.0%, 100g

Camptothecin, >98%, 100mg

8-Bromo-3,4-dihydro-2H-naphthalen-1-one, 95.0%, 250mg

(3-Formyl-5-methylphenyl)boronic acid, 95.0%, 250mg

4-(Trifluoromethyl)phenylacetonitrile>98.0%(GC)5g

2-(2,4-Dichlorophenyl)-1,3-dioxolane, 98%, 10g

Methyl 2-chloro-5-methylisonicotinate, 97%, 10g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 5g

Microliter syringe GASTIGHT® series 1000, 1.0 ml, 1001 TLL, 1 piece

3,4-Dihydropyrazino[1,2-a]indol-1(2H)-one, 95.0%, 1g